Northwestern Medicine scientists have discovered that one of the body's most fundamental biological processes—how red blood ...
Dispatch Bio, the University City-based Penn spinout, is preparing to launch its first human clinical trial for virus-based cancer treatment. A University City biotech founded just three years ago is ...
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...
The SUBITO trial, presented by Rianne L Seefat and colleagues in The Lancet Oncology,1 revisits the long-standing debate ...
Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue and cause ...
Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause ...
Welltica+ on MSN
FDA-approved drug shows promise against liver cancer
Researchers found that an existing FDA-approved drug could make immunotherapy more effective against a rare form of liver ...
AbstractNon apoptotic cell death programs particularly ferroptosis and cuproptosis are transforming how we understand cancer ...
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping ...
Precision medicine is advancing rapidly, but access remains limited. Experts highlight unmet needs, how science is translated ...
One of the most detailed maps to date of meningioma, the most common brain tumor in adults, reveals how the tumor’s ...
One Biosciences receives Paris-Saclay Cancer Cluster (PSCC) BOOST grant to develop first single-cell assay for antibody-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results